This press release is posted as a service by Angioplasty.Org

Cardium Therapeutics, Inc. Company Press Releases February 17, 2010 Cardium Announces Agreement With bioRASI to Advance and Broaden Clinical Development of Generx Product Candidate January 26, 2010 Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell and Gene Therapy Forum November 10, 2008 Cardium Completes $6.0 Million Financing October 23, 2008 Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue™ Endovascular System August 11, 2008 Cardium Reports on Second Quarter 2008 Highlights and Financial Results July 28, 2008 Cardium Announces Appointment of Paul A. Foster, M.D. To Lead Generx and Excellarate Late-Stage Development Activities June 11, 2008 Cardium Launches New AWARE Clinical Study Website May 9, 2008 Cardium Reports on First Quarter 2008 Highlights and Financial Results May 1, 2008 Stent Pioneer Richard A. Schatz, M.D. Joins Cardium's Scientific Advisory Board March 11, 2008 Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion August 28, 2007 Positive Findings on Generx Angiogenesis Therapy for Heart Disease Published in JACC July 25, 2007 Angiogenesis Therapy for Heart Disease Given Fast Track Designation by FDA May 16, 2007 Cardium Initiates Phase 3 AWARE Clinical Study April 17, 2007 Cardium Announces Automated Infusion System for Generx Phase 3 AWARE Study April 9, 2007 Cooler Heads Prevail in Cardiac Arrest March 22, 2007 First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack March 21, 2007 InnerCool's Temperature Modulation Therapy Featured in Men's Health Magazine March 16, 2007 Cardium Reports on Recent Highlights and Financial Results March 6, 2007 Cardium Announces $21.5 Million Equity Financing February 9, 2007 Cardium & InnerCool Announce New External and Internal Patient Temperature Modulation Systems December 7, 2006 Cardium's Generx Advances to Phase 3 Following Meeting with FDA November 30, 2006 Cardium Announces Formation of Scientific Advisory Board October 24, 2006 Cardium Reports on Positive Effects of Hypothermia Following Heart Attack and Announces Clinical Study to Be Co-Sponsored by Swedish Cardiology Center September 21, 2006 Dr. Michael Morgan Reports on Benefits of InnerCool's Celsius Control System in Inducing Hypothermia During Aneurysm Surgery August 31, 2006 Cardium to Present at Roth Capital Partners 2006 New York Conference August 14, 2006 Cardium Acquires Excellarate Product Candidate for Chronic Diabetic Ulcers and Related Technology and Assets From Tissue Repair Company July 11, 2006 Cardium Adopts Stockholder Rights Plan June 5, 2006 Cardium Reports Meta-Analysis of Angiogenic Gene Therapy Studies Shows Positive Effects in Men and Women With Heart Disease June 1, 2006 Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer May 12, 2006 Cardium Therapeutics Post-Effective Amendment No. 1 to Resale Registration Statement Declared Effective May 11, 2006 Federal Appeals Court Rules in Cardium's Favor Over Boston Scientific and Arch Development on Patents for the Treatment of Heart Disease April 5, 2006 Cardium Provides Updated Summary of Generx Clinical Program for Potential Treatment of Coronary Heart Disease March 29, 2006 Cardium Announces Patent Wins Over Boston Scientific and Arch Development Corporation Source: Cardium Therapeutics, Inc.

Angioplasty.Org Home •  PatientCenter

this press release is posted as a reader service by Angioplasty.org,
an independent educational health site
which has received support from
Medtronic, Inc., Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
© Copyright Venture Digital LLC 1996-2010